National Resilience Honored By Goldman Sachs For Entrepreneurship
Rahul Singhvi, CEO, Recognized Among the Most Exceptional Entrepreneurs at 2022 Builders and Innovators Summit
NEWS
Read on
Resilience Becomes Biomanufacturing Resource Partner For California Institute For Regenerative Medicine
Resilience will aid in the development of CIRM grant applications as a biomanufacturing partner with awardees who are developing novel regenerative...
Resilience Announces Collaboration To Manufacture And Deliver Biotherapeutics For Rare And Complex Conditions
Collaboration includes build of embedded process and analytical development labs for use by Mayo Clinic and third-party biotech companies to advance...
The Parker Institute For Cancer Immunotherapy And Resilience Announce Strategic Alliance To Develop Next-Generation Cancer Therapies
Five-year collaboration aims to fund and spin out new companies based on discoveries from PICI’s network of world-leading researchers and with access...
Resilience Announces $625 Million Series D Financing To Expand Network, Bring Innovative Technologies To Biomanufacturing
Up-round financing follows a previously unannounced $600 million Series C Financing completed in August 2021 SAN DIEGO--(BUSINESS WIRE)-- National...
Resilience And MD Anderson Launch Joint Venture To Accelerate Development And Manufacturing Of Innovative Cell Therapies For Cancer
SAN DIEGO & HOUSTON--(BUSINESS WIRE)-- National Resilience, Inc. (Resilience) and The University of Texas MD Anderson Cancer Center today announced...
